Showing results (21-30 of 69) with videos related to
Sort By:
Pageof 7
Psychiatry Research|November 7, 2008
Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is associated with schizophrenia in a Spanish populationAnna Crescenti, Patricia Gassó, Sergi Mas, et al.Psychosomatic Medicine|September 28, 2011
Testosterone in newly diagnosed, antipsychotic-naive men with nonaffective psychosis: a test of the accelerated aging hypothesisEmilio Fernandez-Egea, Clemente García-Rizo, Brian Miller, et al.Schizophrenia Research|August 12, 2011
Prolactin concentrations in newly diagnosed, antipsychotic-naïve patients with nonaffective psychosisClemente Garcia-Rizo, Emilio Fernandez-Egea, Cristina Oliveira, et al.Patient Preference and Adherence|June 18, 2015
Profile of paliperidone palmitate once-monthly long-acting injectable in the management of schizophrenia: long-term safety, efficacy, and patient acceptability - a reviewAlexandre González-Rodríguez, Rosa Catalán, Rafael Penadés, et al.Translational Psychiatry|January 14, 2025
Effectiveness of positive allosteric modulators of metabotropic glutamate receptor 2/3 (mGluR2/3) in animal models of schizophreniaDavid Olivares-Berjaga, Albert Martínez-Pinteño, Natalia Rodríguez, et al.Journal of Psychiatric Research|August 21, 2017
Microarray gene-expression study in fibroblast and lymphoblastoid cell lines from antipsychotic-naïve first-episode schizophrenia patientsPatricia Gassó, Sergi Mas, Natalia Rodríguez, et al.European Archives of Psychiatry and Clinical Neuroscience|May 20, 2009
18FDG PET study of amygdalar activity during facial emotion recognition in schizophreniaEmilio Fernandez-Egea, Eduard Parellada, Francisco Lomeña, et al.Schizophrenia Research|June 16, 2026
Increased brain VDAC1 protein levels correlate with behavioural performance in a ketamine murine model of schizophrenia and are attenuated by the mGluR2 modulator JNJ-46356479David Olivares-Berjaga, Natàlia Rodríguez, Albert Martínez-Pinteño, et al.International Clinical Psychopharmacology|April 17, 2013
Effectiveness of long-acting injectable risperidone versus oral antipsychotics in the treatment of recent-onset schizophrenia: a case-control studyPablo Barrio, Albert Batalla, Pere Castellví, et al.International Journal of Molecular Sciences|May 14, 2025
Mitochondrial Oxidative Phosphorylation System Dysfunction in SchizophreniaConstanza Morén, David Olivares-Berjaga, Albert Martínez-Pinteño, et al.Pageof 7